HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
Condition(s):Sickle Cell DiseaseLast Updated:May 19, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:May 19, 2016Unknown status
Condition(s):Healthy; Sickle Cell DiseaseLast Updated:December 19, 2020Completed
Condition(s):Sickle Cell Hemoglobin C Disease; Hemoglobin S DiseaseLast Updated:September 13, 2021Completed
Condition(s):Genotype; Pain; Genetic Variation; Quantitative Sensory Testing (QST); GCH1Last Updated:December 10, 2020Completed
Condition(s):Sickle Cell Disease; StressLast Updated:July 17, 2015Completed
Condition(s):Sickle Cell DiseaseLast Updated:December 4, 2012Terminated
Condition(s):Anemia, Sickle Cell; PainLast Updated:August 19, 2016Completed
Condition(s):Sickle Cell DiseaseLast Updated:March 15, 2024Recruiting
Condition(s):Preventing Stroke in Sickle Cell AnaemiaLast Updated:September 12, 2018Unknown status
Condition(s):Sickle Cell AnemiaLast Updated:June 28, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.